Seer (SEER) Accumulated Depreciation (2022 - 2026)
Seer (SEER) posted quarterly Accumulated Depreciation of $20.9 million for Q1 2026, up 18.42% year-over-year from $17.7 million in Q1 2025, and up 7.77% quarter-over-quarter from $19.4 million in Q4 2025.
Seer (SEER) Accumulated Depreciation (2022 - 2026) Analysis & Trends
Seer's Accumulated Depreciation history runs 5 years deep, the most recent figure standing at $20.9 million for Q1 2026.
- In Q1 2026, Accumulated Depreciation rose 18.42% year-over-year to $20.9 million; the TTM figure through Mar 2026 stood at $20.9 million (up 18.42% YoY), while the FY2025 annual figure was $19.4 million, up 15.53% from the prior year.
- Accumulated Depreciation for Q1 2026 stood at $20.9 million, up from $19.4 million in the prior quarter.
- The five-year high for Accumulated Depreciation was $20.9 million in Q1 2026, with the low at $7.8 million in Q4 2022.
- The 5-year median for Accumulated Depreciation is $16.8 million (2024), against an average of $16.2 million.
- The sharpest annual moves came in 2023 and 2025: Accumulated Depreciation surged 60.32% in 2023, then rose 10.67% in 2025.
- Seer's Accumulated Depreciation stood at $7.8 million in 2022, then soared by 60.32% to $12.5 million in 2023, then surged by 34.09% to $16.8 million in 2024, then climbed by 15.53% to $19.4 million in 2025, then increased by 7.77% to $20.9 million in 2026.
- Business Quant data shows SEER's Accumulated Depreciation at $20.9 million in Q1 2026, $19.4 million in Q4 2025, and $18.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Seer | 230.63 Mn | 230.63 Mn | 1.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.23 Mn |
| Mar 31, 2026 | 20.94 Mn |
| Dec 31, 2025 | 19.43 Mn |
| Sep 30, 2025 | 18.54 Mn |
| Jun 30, 2025 | 18.81 Mn |
| Mar 31, 2025 | 17.68 Mn |
| Dec 31, 2024 | 16.81 Mn |
| Sep 30, 2024 | 16.75 Mn |
| Jun 30, 2024 | 15.45 Mn |
| Mar 31, 2024 | 13.95 Mn |
| Dec 31, 2023 | 12.54 Mn |
| Dec 31, 2022 | 7.82 Mn |